Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
5-Feb-10 Validea N/A Validea Guru Analysis Report for SSRX. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
28-Jan-10 Zacks Investment Research Inc. N/A 3SBIO INC-ADS (SSRX) Zacks Company Snapshot 1 $10 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
Next 9

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Mar-09 Brean Murray & Co., Inc. Hao Hong Fortnightly Chinese Takeaway: The China Syndrome 6 $30 View Abstract

Independent Reports (Showing 1 to 10 of 18)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
5-Feb-10 Validea N/A Validea Guru Analysis Report for SSRX. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
28-Jan-10 Zacks Investment Research Inc. N/A 3SBIO INC-ADS (SSRX) Zacks Company Snapshot 1 $10 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: 3SBIO INC -ADR 5 $25 View Abstract
Next 8

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.